Stocks
-
186SolarWindow Technologies Inc (OTCMKTS:WNDW) An Exciting Buy After $25 Million Boost
Things are starting to look up for SolarWindow Technologies Inc (OTCMKTS:WNDW) after losing a substantial amount of market value. Improving fundamentals has...
-
655Record Sales and Gross Profit Fuel CV Sciences Inc (OTCMKTS:CVSI)
Tables have turned, and bulls are taking the fight to bears, as CV Sciences Inc (OTCMKTS:CVSI) bounce back continues to gain momentum....
-
439Elev8 Brands Inc (OTCMKTS:VATE) Is A Solid Buy On Debt Reduction, Sales Growth And Cash Flow Prospects
Barely a month after announcing the acquisition of a new distributor in Metro New York, Elev8 Brands Inc (OTCMKTS:VATE) is yet again...
-
264HyperBlock Inc (CNSX:HYPR) Under Pressure Awaiting Crypto Custodial Solution Launch
HyperBlock Inc (CNSX:HYPR) has bounced back from all-time lows after coming under immense pressure from short sellers. Investors could heave a sigh...
-
365IMD Companies Inc (OTCMKTS:ICBU) Turns Bullish On Receiving A $1.7 Billion Purchase Order
A multi-million dollar contract from the Indian government might as well have reinvigorated IMD Companies Inc (OTCMKTS:ICBU) sentiments and prospects. The Company...
-
411Cannex Capital Holdings Inc (CNSX:CNNX) Turns Bullish On Gotham Green Partners $32 Million Capital Investment
Cannex Capital Holdings Inc (CNSX:CNNX) is a breakout stock headed into the year-end, after a long period of consolidation. The stock has...
-
601Why Trulieve Cannabis Corp (OTCMKTS:TCNNF) Is Undervalued
Trulieve Cannabis Corp (OTCMKTS:TCNNF) has achieved significant milestones, on the operational front, ever since it became a public company. However, the same...
-
576Rocky Mountain High Brands Inc (OTCMKTS:RMHB) Undervalued On Improving Fundamentals
Rocky Mountain High Brands Inc (OTCMKTS:RMHB) sentiments in the market have turned from bad to worse. The share price has taken a...
-
400Nemus Bioscience Inc (OTCMKTS:NMUS) Turns Bullish On Emerald Health $20 Million Credit Line Boost
Nemus Bioscience Inc (OTCMKTS:NMUS) continues to elicit strong investor interest after reaching an agreement for a $20 million credit facility. With the...
-
433GT Biopharma Inc. (OTCMKTS:GTBP): FDA Clinical Trials Clearance Reinvigorates Long-Term Prospects
A third quarter financial report attesting to a solid foundation for long-term growth might as well be the catalyst, poised to trigger...
